# GRI (GRI Bio, Inc.) - SEC EDGAR Financial Statements

> GRI Bio, Inc. reported $9.76M in total assets and a net loss of $7.81M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/GRI
- Markdown: https://convexityos.com/fundamentals/GRI.md
- SEC CIK: 0001824293
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001824293&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$7.83M | Operating profit |
| Net Income | FY 2025 | -$7.81M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$3.57 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$10.19M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $9.47M | Total debt: $30K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | $0 | $100K |
| Research & Development | $6.82M | $3.77M | $3.23M | $242K | $5.19M | $3.71M |
| Total Operating Expenses | $11.98M | $8.23M | $11.39M | $2.24M | $9.26M | $4.89M |
| **Operating Income** | -$11.98M | -$8.23M | -$11.39M | -$2.24M | -$9.26M | -$4.79M |
| **EBITDA** | -$11.97M | -$8.23M | -$11.38M | -$2.24M | -- | -- |
| Income Tax Expense | $3.0K | $2.0K | -- | -- | -- | -- |
| **Net Income** | -$11.96M | -$8.21M | -$13.04M | -$3.22M | -$9.30M | -$4.82M |
| Basic EPS | -$121.80 | -$1,545.55 | -$6,693,487,957.60 | -$160,854,335,804,675,328.00 | -$274,919,998,366,268,864.00 | -$207,158,026,937,963,200.00 |
| **Diluted EPS** | -$121.80 | -$1,545.55 | -$6,693,487,957.60 | -$160,854,335,804,675,328.00 | -$274,919,998,366,268,864.00 | -$207,158,026,937,963,200.00 |
| Basic Shares Outstanding | 98.2K | 6.5K | 0 | 0 | 0 | 0 |
| Diluted Shares Outstanding | 98.2K | 6.5K | 0 | 0 | 0 | 0 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $212K | $407K | $361K | $1.63M | $1.77M | $1.88M | $1.64M | $907K |
| Total Operating Expenses | $1.51M | $1.65M | $2.00M | $2.66M | $3.37M | $2.90M | $3.05M | $1.95M |
| **Operating Income** | -$1.51M | -$1.65M | -$2.00M | -$2.66M | -$3.37M | -$2.90M | -$3.05M | -$1.95M |
| **EBITDA** | -$1.51M | -$1.65M | -$2.00M | -$2.66M | -$3.36M | -$2.90M | -$3.05M | -$1.95M |
| **Net Income** | -$1.51M | -$1.64M | -$2.00M | -$2.66M | -$3.36M | -$2.89M | -$3.05M | -$1.95M |
| Basic EPS | -$0.69 | -$0.91 | -$1.61 | -- | -$35.88 | -$36.72 | -$162.30 | -- |
| **Diluted EPS** | -$0.69 | -$0.91 | -$1.61 | -- | -$35.88 | -$36.72 | -$162.30 | -- |
| Basic Shares Outstanding | 2.2M | 1.8M | 1.2M | -- | 93.6K | 78.8K | 18.8K | -- |
| Diluted Shares Outstanding | 2.2M | 1.8M | 1.2M | -- | 93.6K | 78.8K | 18.8K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.23M | $5.03M | $1.81M | $9.0K | $3.70M | $109K |
| Short-Term Investments | -- | -- | -- | $0 | $3.81M | $0 |
| **Cash & Short-Term Investments** | $8.23M | $5.03M | $1.81M | $9.0K | $7.51M | $109K |
| **Total Current Assets** | $8.59M | $5.62M | $2.93M | $312K | $8.13M | $674K |
| Property, Plant & Equipment, Net | $3.0K | $4.0K | $8.0K | $4.0K | $0 | $2.0K |
| Other Non-Current Assets | -- | -- | -- | $0 | $206K | $279K |
| **Total Non-Current Assets** | $74K | $124K | $22K | $71K | $206K | $281K |
| **Total Assets** | $8.67M | $5.74M | $2.96M | $383K | $8.34M | $955K |
| Accounts Payable | $1.84M | $897K | $1.41M | $1.29M | $918K | $1.23M |
| Other Current Liabilities | -- | -- | -- | $0 | $97K | $105K |
| **Total Current Liabilities** | $2.64M | $1.64M | $2.70M | $1.99M | $2.44M | $2.23M |
| Other Non-Current Liabilities | -- | -- | -- | $0 | $72K | $170K |
| **Total Non-Current Liabilities** | $15K | $71K | $0 | $14K | $72K | $184K |
| **Total Liabilities** | $2.66M | $1.71M | $2.70M | $2.01M | $2.52M | $2.41M |
| **Total Debt (incl. Leases)** | $71K | $119K | $14K | $71K | $169K | $275K |
| Retained Earnings | -$51.70M | -$39.74M | -$31.53M | -$18.50M | -$21.90M | -$12.60M |
| Accumulated Other Comp. Income | -- | -- | -- | $0 | -$2.0K | $0 |
| **Total Stockholders' Equity** | $6.01M | $4.03M | $259K | -$1.62M | -$4.85M | -$1.45M |
| Total Equity | $6.01M | $4.03M | $259K | -$1.62M | -$4.85M | -$1.45M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $9.47M | $10.95M | $11.05M | $8.23M | $4.05M | $5.12M | $3.28M | $5.03M |
| **Cash & Short-Term Investments** | $9.47M | $10.95M | $11.05M | $8.23M | $4.05M | $5.12M | $3.28M | $5.03M |
| **Total Current Assets** | $9.73M | $11.33M | $11.28M | $8.59M | $4.70M | $5.58M | $3.93M | $5.62M |
| Property, Plant & Equipment, Net | $2.0K | $2.0K | $2.0K | $3.0K | $1.0K | $2.0K | $3.0K | $4.0K |
| **Total Non-Current Assets** | $32K | $46K | $60K | $74K | $85K | $99K | $112K | $124K |
| **Total Assets** | $9.76M | $11.38M | $11.34M | $8.67M | $4.78M | $5.67M | $4.04M | $5.74M |
| Accounts Payable | $354K | $526K | $303K | $1.84M | $1.32M | $1.30M | $1.36M | $897K |
| **Total Current Liabilities** | $953K | $1.10M | $794K | $2.64M | $2.76M | $2.31M | $2.78M | $1.64M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $15K | $30K | $44K | $58K | $71K |
| **Total Liabilities** | $953K | $1.10M | $794K | $2.66M | $2.79M | $2.35M | $2.84M | $1.71M |
| **Total Debt (incl. Leases)** | $30K | $44K | $58K | $71K | $84K | $96K | $108K | $119K |
| Retained Earnings | -$56.84M | -$55.34M | -$53.69M | -$51.70M | -$49.04M | -$45.68M | -$42.79M | -$39.74M |
| **Total Stockholders' Equity** | $8.81M | $10.28M | $10.54M | $6.01M | $1.99M | $3.32M | $1.21M | $4.03M |
| Total Equity | $8.81M | $10.28M | $10.54M | $6.01M | $1.99M | $3.32M | $1.21M | $4.03M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.96M | -$8.21M | -$13.04M | -$3.22M | -$9.30M | -$4.82M |
| Depreciation & Amortization | $4.0K | $4.0K | $4.0K | $3.0K | -- | -- |
| Stock-Based Compensation | $793K | $148K | $388K | $25K | $626K | $154K |
| Change in Payables | $663K | -$387K | $2.16M | $897K | -$308K | $980K |
| **Operating Cash Flow** | -$10.19M | -$8.61M | -$8.99M | -$1.08M | -$8.31M | -$3.71M |
| Capital Expenditure | -$3.0K | $0 | -$8.0K | -$3.0K | $0 | -$2.0K |
| **Free Cash Flow** | -$10.19M | -$8.61M | -$9.00M | -$1.09M | -$8.31M | -$3.71M |
| Purchases of Investments | -- | -- | -- | -$640K | -$3.84M | $0 |
| **Investing Cash Flow** | -$3.0K | $0 | -$8.0K | -$3.0K | -$3.84M | -$2.0K |
| Common Stock Issued | -- | -- | $12.25M | $0 | -- | -- |
| **Financing Cash Flow** | $13.39M | $11.83M | $10.80M | $1.01M | $15.75M | -$4.0K |
| **Net Change in Cash** | $3.20M | $3.22M | $1.80M | -$81K | $3.59M | -$3.71M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.51M | -$1.64M | -$2.00M | -$2.66M | -$3.36M | -$2.89M | -$3.05M | -$1.95M |
| Depreciation & Amortization | $0 | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Stock-Based Compensation | $32K | $33K | $31K | $67K | $465K | $41K | $220K | $37K |
| Change in Payables | -$172K | $223K | -$1.51M | $272K | $20K | $40K | $331K | -$240K |
| **Operating Cash Flow** | -$1.48M | -$1.45M | -$3.69M | -$2.97M | -$2.31M | -$3.17M | -$1.74M | -$2.00M |
| Common Stock Issued | -- | -- | $6.82M | -- | -- | -- | $0 | -- |
| **Financing Cash Flow** | $0 | $1.34M | $6.50M | $7.15M | $1.25M | $5.01M | -$11K | $2.28M |
| **Net Change in Cash** | -$1.48M | -$101K | $2.82M | $4.17M | -$1.07M | $1.84M | -$1.75M | $282K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -4788.0% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -4822.0% |
| Return on Equity (ROE) | -199.0% | -203.5% | -5033.6% | -- | -- | -- |
| Return on Assets (ROA) | -138.0% | -143.0% | -441.0% | -839.9% | -111.6% | -504.9% |
| Current Ratio | 3.25x | 3.43x | 1.09x | 0.16x | 3.32x | 0.30x |
| Quick Ratio | 3.11x | 3.07x | 0.67x | 0.00x | 3.07x | 0.05x |
| Debt to Equity | 0.01x | 0.03x | 0.05x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -100.0% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -88.6% | -94.0% | -103.4% | -199.0% | -564.2% | -301.3% | -777.3% | -203.6% |
| Return on Assets (ROA) | -80.0% | -84.9% | -96.2% | -138.0% | -235.2% | -176.4% | -231.7% | -143.0% |
| Current Ratio | 10.21x | 10.30x | 14.21x | 3.25x | 1.70x | 2.41x | 1.41x | 3.43x |
| Quick Ratio | 9.94x | 9.95x | 13.91x | 3.11x | 1.47x | 2.22x | 1.18x | 3.07x |
| Debt to Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.04x | 0.03x | 0.09x | 0.03x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
